Long Term Open Label Treatment with Inhaled Treprostinil for Pulmonary Arterial Hypertension

被引：0
|
作者：
Voswinckel, R. [1 ]
van Dijk, J. [2 ]
Edelmann, R. [1 ]
Gall, H. [1 ]
Channick, R. [2 ]
Olschewski, H. [3 ]
Ghofrani, H. A. [1 ]
Seeger, W. [1 ]
Rubin, L. J. [2 ]
机构：
[1] Univ Giessen, Lung Ctr, D-35390 Giessen, Hesse, Germany
[2] UCSD, La Jolla, CA USA
[3] Univ Hosp Graz, Graz, Austria
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3352
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Transition From Inhaled Treprostinil to Selexipag in Pulmonary Arterial Hypertension
    El-Kersh, Karim
    Smith, J. Shaun
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (05) : E620 - E621
  • [22] An Open-Label Extension Trial Of Oral Treprostinil In Subjects With Pulmonary Arterial Hypertension
    White, R. J.
    Jing, Z. -C.
    Parikh, K.
    Bartolome, S.
    Allen, R. P.
    Xu, K. -F.
    Shapiro, S.
    Feldman, J.
    Crawford, K.
    Arneson, C.
    Laliberte, K.
    Tapson, V. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [23] Inhaled treprostinil for pulmonary hypertension
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (2): : 64 - 65
  • [24] Safely Transitioning from Inhaled Iloprost to Inhaled Treprostinil Sodium - Results from a Multicenter Open-Label Study in Patients with Pulmonary Arterial Hypertension
    Bourge, R. C.
    Tapson, V. F.
    Safdar, Z.
    Benza, R. L.
    Channick, R. N.
    Rosenzweig, E. B.
    Shapiro, S.
    McSwain, C. S.
    Gotzkowsky, A.
    Nelsen, A.
    Rubin, L. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S71 - S72
  • [25] Long-Term Treatment of Pulmonary Arterial Hypertension with Treprostinil in Patient with Eisenmenger and Down Syndromes
    Gasior, Z.
    Sikora-Puz, A.
    Banska-Kisiel, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [26] Long-Term Efficacy of Oral Treprostinil in Subjects with Pulmonary Arterial Hypertension: FREEDOM-EV Open-Label Extension Study
    White, R. J.
    Broderick, M.
    Deng, C. Q.
    Grover, R.
    Holdstock, L.
    Khan, A.
    Bohns Meyer, G.
    Ng, B.
    Pulido Zamudio, T.
    Saib, I.
    Sepulveda, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [27] Inhaled treprostinil sodium (TRE) for the treatment of pulmonary hypertension
    Voswinckel, R
    Enke, B
    Kreckel, A
    Reichenberger, F
    Krick, S
    Gall, H
    Gessler, T
    Schmehl, T
    Kohstall, MG
    Grimminger, F
    Ghofrani, HA
    Seeger, W
    Olschewski, H
    CIRCULATION, 2004, 110 (17) : 295 - 295
  • [28] ORAL TREPROSTINIL FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
    de Lartigue, J.
    DRUGS OF TODAY, 2014, 50 (08) : 557 - 565
  • [29] Acute Pulmonary Vasodilator Testing With Inhaled Treprostinil in Children With Pulmonary Arterial Hypertension
    Takatsuki, Shinichi
    Parker, Donna K.
    Doran, Aimee K.
    Friesen, Robert H.
    Ivy, D. Dunbar
    PEDIATRIC CARDIOLOGY, 2013, 34 (04) : 1006 - 1012
  • [30] Acute Pulmonary Vasodilator Testing With Inhaled Treprostinil in Children With Pulmonary Arterial Hypertension
    Shinichi Takatsuki
    Donna K. Parker
    Aimee K. Doran
    Robert H. Friesen
    D. Dunbar Ivy
    Pediatric Cardiology, 2013, 34 : 1006 - 1012
12345